Ignite Creation Date:
2024-05-06 @ 6:12 PM
Last Modification Date:
2024-10-26 @ 2:43 PM
Study NCT ID:
NCT05577468
Status:
COMPLETED
Last Update Posted:
2024-01-10
First Post:
2022-10-09
Brief Title:
Efficacy and Safety of Tegoprazan Versus Esomeprazole-containing Bismuth Quadruple Therapy for Eradication of Helicobacter Pylori
Sponsor:
Shandong Luoxin Pharmaceutical Group Stock Co Ltd
Organization:
Shandong Luoxin Pharmaceutical Group Stock Co Ltd
Organization Data
Organization:
Shandong Luoxin Pharmaceutical Group Stock Co Ltd
Class:
INDUSTRY
Study ID:
NC822101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Shandong Luoxin Pharmaceutical Group Stock Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None